Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-28T04:44:23.207Z Has data issue: false hasContentIssue false
  • English
  • Français

National trends (2003–2009) and factors related to psychotropic medication use in community-dwelling elderly population

Published online by Cambridge University Press:  15 October 2012

P. Carrasco-Garrido ,
A. López de Andrés ,
V. Hernández Barrera ,
Isabel Jiménez-Trujillo  and
R. Jiménez-García
P. Carrasco-Garrido*
Affiliation:
Department of Preventive Medicine and Public Health, Rey Juan Carlos University, Alcorcón, Madrid, Spain
A. López de Andrés
Affiliation:
Department of Preventive Medicine and Public Health, Rey Juan Carlos University, Alcorcón, Madrid, Spain
V. Hernández Barrera
Affiliation:
Department of Preventive Medicine and Public Health, Rey Juan Carlos University, Alcorcón, Madrid, Spain
Isabel Jiménez-Trujillo
Affiliation:
Department of Preventive Medicine and Public Health, Rey Juan Carlos University, Alcorcón, Madrid, Spain
R. Jiménez-García
Affiliation:
Department of Preventive Medicine and Public Health, Rey Juan Carlos University, Alcorcón, Madrid, Spain
*
Correspondence should be addressed to: P. Carrasco-Garrido, PhD, MPH, Department of Preventive Medicine and Public Health, Rey Juan Carlos University, Avda. Atenas s/n. Alcorcón, Madrid, Spain. Phone: +34-914888877; Fax: +34-914888955. Email: pilar.carrasco@urjc.es.
Get access

Abstract

Background: We aimed to analyze the prevalence of prescription anxiolytics and antidepressants in elderly individuals in Spain between the years 2003 and 2009, and to identify those factors associated with the likelihood of consumption of these drugs during the study period.

Methods: We used individualized secondary data retrieved from the 2003 and 2006 Spanish National Health Surveys (SNHS) and the 2009 European Health Interview Survey (EHIS) for Spain to conduct a nationwide, descriptive, cross-sectional pharmacoepidemiology study on psychotropic medication in the population aged 65 years and over in Spain. A total of 12,228 interviews were analyzed (5,117 from 2003; 7,084 from 2006; and 5,144 from 2009). The dichotomous dependent variables chosen were the answers “yes” or “no” to the question “In the last two weeks have you taken the following medicines and were they prescribed for you by a doctor?” referring to intake of anxiolytics and antidepressants. Independent variables were sociodemographic, comorbidity, and healthcare resources.

Results: Multivariate analysis highlighted the association between increased psychoactive drug intake and female gender, depression, polypharmacy, and negative perception of health. We observed a significant increase in the consumption of prescription anxiolytics (AOR, 1.08 [95% CI, 1.06–1.10]) and antidepressants (AOR, 1.11 [95% CI, 1.08–1.14]) in individuals aged ≥65 years in Spain between the years 2003 and 2009.

Conclusions: The prevalence of anxiolytics and antidepressants consumption is higher in elderly women than men, and increases with negative perception of health. The Spanish elderly individuals taking antidepressants reported having problems to manage these medicines in their own homes.

Keywords

psychotropic medicationelderlynational surveygenderpolypharmacy
Type
Research Article
Information
International Psychogeriatrics , Volume 25 , Issue 2 , February 2013 , pp. 328 - 338
Copyright
Copyright © International Psychogeriatric Association 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akazawa, M., Imai, H., Igarashi, A. and Tsutani, K. (2010). Potentially inappropriate medication use in elderly Japanese patients. American Journal of Geriatric Pharmacotherapy, 8, 146–160.CrossRefGoogle ScholarPubMed
Blasco, F., López de Letona, J., Villares, P. and Jiménez, A. I. (2005). El paciente anciano polimedicado: efectos sobre su salud y sobre el sistema sanitario. Información Terapéutica del Sistema Nacional de Salud, 29, 152–162.Google Scholar
Blumstein, T., Benyamini, Y., Chetrit, A., Mizrahi, E. H. and Lerner-Geva, L. (2012). Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart. Aging and Mental Health, 16, 636–647.CrossRefGoogle ScholarPubMed
Carrasco-Garrido, P., Jiménez-García, R., Astasio-Arbiza, P., Ortega-Molina, P. and de Miguel, A. G. (2007). Psychotropics use in the Spanish elderly: predictors and evolution between years 1993 and 2003. Pharmacoepidemiology and Drug Safety, 16, 449–457.CrossRefGoogle ScholarPubMed
Codony, M.et al. (2007). Psychotropic medications use in Spain: results of the ESEMeD-Spain study. Actas Españolas de Psiquiatría, 35, 29–36.Google ScholarPubMed
Covinsky, K. E., Yaffe, K., Lindquist, K., Cherkasova, E., Yelin, E. and Blazer, D. G. (2010). Depressive symptoms in middle age and the development of later-life functional limitations: the long-term effect of depressive symptoms. Journal of American Geriatric Society, 58, 551–556.CrossRefGoogle ScholarPubMed
Crentsil, V., Ricks, M. O., Xue, Q. L. and Fried, L. P. (2010). A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. American Journal of Geriatric Pharmacotherapy, 8, 215–224.CrossRefGoogle ScholarPubMed
Demyttenaere, K.et al. (2008). Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). Journal of Affective Disorders, 110, 84–93.CrossRefGoogle ScholarPubMed
Desplenter, F., Caenen, C., Meelberghs, J., Hartikainen, S., Sulkava, R. and Bell, J. S. (2011). Change in psychotropic drug use among community-dwelling people aged 75 years and older in Finland: repeated cross-sectional population studies. International Psychogeriatrics, 23, 1278–1284.CrossRefGoogle ScholarPubMed
Fortin, D.et al. (2005). Factors associated with short- and long-term use of benzodiazepines in the elderly from Quebec. Canadian Journal of Aging, 24, 103–113.CrossRefGoogle Scholar
Fourrier, A., Letenneur, L., Dartigues, J. F., Moore, N. and Begaud, B. (2001). Benzodiazepine use in an elderly community-dwelling population: characteristic of users and factors associated with subsequent use. European Journal of Clinical Pharmacology, 57, 419–425.CrossRefGoogle Scholar
Gabilondo, A.et al. (2010). Epidemiology of major depressive episode in a southern European country: results from the ESEMeD-Spain project. Journal of Affective Disorders, 12, 76–85.CrossRefGoogle Scholar
Hämäläinen, J., Isometsä, E., Sihvo, S., Kiviruusu, O., Pirkola, S. and Lönnqvist, J. (2009). Treatment of major depressive disorder in the Finnish general population. Depression and Anxiety, 26, 1049–1059.CrossRefGoogle ScholarPubMed
Haro, J. M.et al. (2006). Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study. Medicina Clínica, 126, 445–451.CrossRefGoogle ScholarPubMed
INE (Instituto Nacional de Estadística). (2005). Encuesta Nacional de Salud de España 2003 (Spanish National Health Survey 2003). Available at: http://www.ine.es/en/metodologia/t15/t1530419_en.pdf.Google Scholar
INE. (2008). Encuesta Nacional de Salud de España 2006 (Spanish National Health Survey 2006). Available at: http://www.ine.es/jaxi/menu.do?L=0&type=pcaxis&path=/t15/p419&file=inebase.Google Scholar
INE. (2011). Encuesta Europea de Salud para España 2009 (European Health Survey for Spain 2009). Available at: http://www.msc.es/estadEstudios/estadisticas/EncuestaEuropea/Metodologia_EES_2009.pdf.Google Scholar
Jónsdóttir, H.et al. (2010). Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. Journal of Clinical Psychopharmacology, 30, 169–175.CrossRefGoogle ScholarPubMed
Kairuz, T.et al. (2008). Identifying compliance issues with prescription medicines among older people: a pilot study. Drug and Aging, 25, 153–162.CrossRefGoogle ScholarPubMed
King-Kallimanis, B., Gum, A. M. and Kohn, R. (2009). Comorbidity of depressive and anxiety disorders for older Americans in the national comorbidity survey-replication. American Journal of Geriatric Psychiatry, 17, 782–792.CrossRefGoogle ScholarPubMed
Lai, H. Y., Hwang, S. J., Chen, Y. C., Chen, T. J., Lin, M. H. and Chen, L. K. (2009). Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Clinical Therapeutics, 31, 1859–1870.CrossRefGoogle ScholarPubMed
Lesén, E., Andersson, K., Petzold, M. and Carlsten, A. (2010). Socioeconomic determinants of psychotropic drug utilization among elderly: a national population-based cross-sectional study. BMC Public Health, 10, 118.CrossRefGoogle ScholarPubMed
Marengoni, A.et al. (2011). Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients. International Psychogeriatrics, 8, 1–8.Google Scholar
Mastroianni, P. C., Vaz, A. C., Noto, A. R. and Galduróz, J. C. (2008). Psychoactive drug advertising: content analysis. Revista de Saude Publica, 42, 968–971.CrossRefGoogle ScholarPubMed
Ministerio de Sanidad, Servicios Sociales e Igualdad. (2006). Subgrupos ATC y Principios activos de mayor consumo en el Sistema Nacional de Salud en 2005. Información Terapéutica del Sistema Nacional de Salud. Available at: http://www.msssi.gob.es/biblioPublic/publicaciones/recursos_propios/infMedic/docs/SubgruposATCvol35n4.pdf.Google Scholar
Ministerio de Sanidad, Servicios Sociales e Igualdad. (2011). Subgrupos ATC y Principios activos de mayor consumo en el Sistema Nacional de Salud en 2010. Información Terapéutica del Sistema Nacional de Salud. Available at: http://www.msssi.gob.es/biblioPublic/publicaciones/docs/subgruposAtc.pdf.Google Scholar
Mojtabai, R. and Olfson, , , M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry, 67, 26–36.CrossRefGoogle ScholarPubMed
Ohayon, M. M. (2007). Epidemiology of depression and its treatment in the general population. Journal of Psychiatric Research, 41, 207–213.CrossRefGoogle ScholarPubMed
Patten, S. B., Williams, J. V., Lavorato, D. H., Khaled, S. and Bulloch, A. G. (2011). Weight gain in relation to major depression and antidepressant medication use. Journal of Affective Disorders, 134, 288–293.CrossRefGoogle ScholarPubMed
Paulose-Ram, R., Safran, M. A., Jonas, B. S., Gu, Q. and Orwig, D. (2007). Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiology and Drug Safety, 16, 560–570.CrossRefGoogle ScholarPubMed
Payne, R. A. and Avery, A. J. (2011). Polypharmacy: one of the greatest prescribing challenges in general practice. British Journal of General Practice, 61, 83–84.CrossRefGoogle ScholarPubMed
Pélissolo, A., Maniere, F., Boutges, B., Allouche, M., Richard-Berthe, C. and Corruble, E. (2007). Anxiety and depressive disorders in 4,425 long term benzodiazepine users in general practice. Encephale, 33, 32–38.CrossRefGoogle ScholarPubMed
Rikala, M., Korhonen, M. J., Sulkava, R. and Hartikainen, S. (2011). Psychotropic drug use in community-dwelling elderly people: characteristics of persistent and incident users. European Journal of Clinical Pharmacology, 67, 731–739.CrossRefGoogle ScholarPubMed
Ruiz-Cantero, M. T. and Verdú-Delgado, M. (2004). Gender bias in treatment. Gaceta Sanitaria, 18, 118–125.CrossRefGoogle ScholarPubMed
Soudry, A., Dufouil, C., Ritchie, K., Dartigues, J. F., Tzourio, C. and Alpérovitch, A. (2008). Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study. European Journal of Clinical Pharmacology, 64, 51–59.CrossRefGoogle Scholar
Tordoff, J., Simonsen, K., Thomson, W. M. and Norris, P. T. (2010). “It's just routine”: a qualitative study of medicine-taking amongst older people in New Zealand. Pharmacy World Sciences, 32, 154–161.CrossRefGoogle ScholarPubMed
Voyer, P., Preville, M., Roussel, M. E., Berbiche, D. and Beland, S. G. (2009). Factors associated with benzodiazepine dependence among community-dwelling seniors. Journal of Community Health Nursing, 26, 101–113.CrossRefGoogle ScholarPubMed
Zhang, Y.et al. (2010). Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing. International Psychogeriatrics, 22, 437–444.CrossRefGoogle ScholarPubMed